Getagraph.com logo
S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

リアルタイムの更新： Apexigen, Inc. [APGN]

取引所: NASDAQ Capital Market セクター: Healthcare 産業: Biotechnology
最終更新日時23 8月 2023 @ 04:59
25% discount on Stockinvest.us - Use code: Podcast

8.48% $ 0.385

Live Chart Being Loaded With Signals

Commentary (23 8月 2023 @ 04:59):

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells...

Stats
本日の出来高 94 426.00
平均出来高 262 332
時価総額 9.57M
EPS $0 ( 2023-11-21 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.225
ATR14 $0.0390 (10.13%)
Insider Trading
Date Person Action Amount type
2023-08-23 Zabrowksi Dan Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 146 383 Common Stock
2023-08-23 Wertheimer Samuel P Sell 100 000 Stock Option (right to buy)
2023-08-23 Wertheimer Samuel P Sell 12 383 Warrants (right to buy)
2023-08-23 Wertheimer Samuel P Sell 1 845 Warrants (right to buy)
INSIDER POWER
-60.29
Last 97 transactions
Buy: 2 466 920 | Sell: 6 182 886

ボリューム 相関

長: 0.28 (neutral)
短: 0.00 (neutral)
Signal:(44.278) Neutral

Apexigen, Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Apexigen, Inc. 相関 - 通貨/商品

The country flag -0.66
( moderate negative )
The country flag -0.33
( neutral )
The country flag 0.00
( neutral )
The country flag -0.67
( moderate negative )
The country flag 0.57
( weak )

Apexigen, Inc. 財務諸表

Annual 2022
収益: $0
総利益: $0 (0.00 %)
EPS: $-1.590
FY 2022
収益: $0
総利益: $0 (0.00 %)
EPS: $-1.590
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.931
FY 2020
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-3.36

Financial Reports:

No articles found.

Apexigen, Inc.

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。